©istock.com/Andrea Obzerova
Interdisciplinary CompetenceMolecular Diagnostics
Know how in the analysis of genetic material.
For the benefit of patients.

IllnessPränatal auffällige Nieren/Urogenitalsystem, Differentialdiagnose

Summary

Short information

Comprehensive differential diagnostic panel for Prenatally abnormal kidneys / urinary tract comprising 13 or altogether 69 curated genes according to the clinical signs

ID
PP0015
Number of loci
Loci typeCount
Gen67
Accredited laboratory test
Examined sequence length
21,9 kb (Core-/Core-canditate-Genes)
224,2 kb (Extended panel: incl. additional genes)
Analysis Duration
on request
Test material
  • Amniotic fluid (after amnocentesis)
  • Chorionic villus
  • Umbilical cord blood
Diagnostic indications

NGS +

[Sanger]

 

Loci panel

Gen

NameExon Length (bp)OMIM-GReferenz-Seq.Heredity
HNF1B1674NM_000458.4AD
NPHP33993NM_153240.5AR
PKHD112225NM_138694.4AR
RPGRIP1L3948NM_015272.5AR
ACE3921NM_000789.4AR
ACTG21131NM_001615.4AD
ANOS12043NM_000216.4XLR
BMP41227NM_001202.6AD
BNC23297NM_017637.6AD
CHD78994NM_017780.4AD
CHRNA31518NM_000743.5AR
CRB23858NM_173689.7AR
DHCR71428NM_001360.3AR
DSTYK2790NM_015375.3AD
EYA11779NM_000503.6AD
FANCB2580NM_001018113.3XLR
FGF20636NM_019851.3AR
FOXC21506NM_005251.3AD
FRAS112039NM_025074.7AR
FREM16540NM_144966.7AR
FREM29510NM_207361.6AR
GATA31335NM_001002295.2AD
GLI34743NM_000168.6AD
GPC31743NM_004484.4XLR
GRIP13231NM_021150.4AR
HOXA131167NM_000522.5AD
HPSE21605NM_001166244.1AR
ITGA83192NM_003638.3AR
JAG13657NM_000214.3AD
KDM6A4206NM_021140.4XL
KMT2D16614NM_003482.4AD
KYNU924NM_001032998.2AR
LIFR3294NM_002310.6AD
LMOD11806NM_012134.3AR
LRIG23198NM_014813.3AR
LRP45718NM_002334.4AR
MYH115919NM_002474.3AR
MYL9522NM_006097.5AR
MYLK5745NM_053025.4AR
MYOCD2961NM_001146312.3AD, AR
NIPBL8415NM_133433.4AD
NR0B11413NM_000475.5XL
NRIP13477NM_003489.4AD
PAX21254NM_003987.5AD
PBX11293NM_002585.4AD
REN1221NM_000537.4AR, AD
RET3345NM_020975.6AD, AR
ROBO24185NM_001128929.3AD
ROR22832NM_004560.4AD, AR
RRM2B1272NM_015713.5AR
SALL13975NM_002968.3AD
SALL43162NM_020436.5AD
SAMD94770NM_001193307.2AD
SIX1855NM_005982.4AD
SIX52220NM_175875.5AD
SLC12A13300NM_000338.3AR
SOX171245NM_022454.4AD
STRA62004NM_001142617.2AR
TBC1D13480NM_001253912.2AD
TBX181824NM_001080508.3AD
TFAP2A1296NM_001032280.3AD
TRAP12115NM_016292.3AR
VIPAS391482NM_022067.4AR
VPS33B1854NM_018668.5AR
WNT41056NM_030761.5AD, AR
WNT5A1143NM_003392.7AD
ZIC31404NM_003413.4XLR

Informations about the disease

Clinical Comment

Congenital abnormalities of kidneys + urinary tract are the most common sonographically identified malformations prenatally. Obstructive uropathies account for the majority of cases. The aim of prenatal diagnosis + management is to detect those anomalies having impact on prognosis of the affected child, requiring early postnatal evaluation/treatment to minimize adverse outcomes.

 

Synonyms
  • Alias: Congenital Anomalies of the Kidney and Urinary Tract - CAKUT
  • Alias: Prenatally unusual ultrasound findings in urinary tract
  • Alias: Renal or urinary tract malformation
  • Allelic: Bone marrow failure [panelapp] (EXOC3L)
  • Allelic: Branchiootic syndrome 3 (SIX1)
  • Allelic: Dandy-Walker malformation [panelapp] (EXOC3L)
  • Allelic: Deafness, AD 23 (SIX1)
  • Allelic: Deafness, AD 80 (GREB1L)
  • Allelic: Diabetes mellitus, noninsulin-dependent (HNF1B)
  • Allelic: Diarrhea 10, protein-losing enteropathy type (PLVAP)
  • Allelic: Hydroxykynureninuria (KYNU)
  • Allelic: Hypertension, essential, susceptibility to (AGT)
  • Allelic: Hyperuricemic nephropathy, familial juvenile 2 (REN)
  • Allelic: Manitoba oculotrichoanal syndrome (FREM1)
  • Allelic: Nephronophthisis 3 (NPHP3)
  • Allelic: Renal cell carcinoma (HNF1B)
  • Allelic: Retinitis pigmentosa 23 (OFD1)
  • Allelic: Spermatogenic failure 72 (WDR19)
  • Allelic:Preeclampsia, susceptibility to (AGT)
  • 46XY sex reversal 2, dosage-sensitive (NR0B1)
  • Adrenal hypoplasia, congenital (NR0B1)
  • Alagille syndrome 1 (JAG1)
  • Alagille syndrome 2 (NOTCH2)
  • Arthrogryposis, renal dysfunction, + cholestasis 1 (VPS33B)
  • Bardet-Biedl syndrome 1 (BBS1)
  • Bardet-Biedl syndrome 1, modifier of (ARL6)
  • Bardet-Biedl syndrome 1, modifier of (CCDC28B)
  • Bardet-Biedl syndrome 10 (BBS10)
  • Bardet-Biedl syndrome 11 (TRIM32)
  • Bardet-Biedl syndrome 12 (BBS12)
  • Bardet-Biedl syndrome 13 (MKS1)
  • Bardet-Biedl syndrome 14 (CEP290)
  • Bardet-Biedl syndrome 14, modifier of (TMEM67)
  • Bardet-Biedl syndrome 15 (WDPCP)
  • Bardet-Biedl syndrome 16 (SDCCAG8)
  • Bardet-Biedl syndrome 17 (LZTFL1)
  • Bardet-Biedl syndrome 18 (BBIP1)
  • Bardet-Biedl syndrome 19 (IFT27)
  • Bardet-Biedl syndrome 2 (BBS2)
  • Bardet-Biedl syndrome 20 (IFT172)
  • Bardet-Biedl syndrome 21 (CFAP418)
  • Bardet-Biedl syndrome 22 (IFT74)
  • Bardet-Biedl syndrome 3 (ARL6)
  • Bardet-Biedl syndrome 4 (BBS4)
  • Bardet-Biedl syndrome 5 (BBS5)
  • Bardet-Biedl syndrome 6 (MKKS)
  • Bardet-Biedl syndrome 7 (BBS7)
  • Bardet-Biedl syndrome 8 (TTC8)
  • Bardet-Biedl syndrome 9 (PTHB1)
  • Bartter syndrome, type 1 (SLC12A1)
  • Bifid nose with/-out anorectal + renal anomalies (FREM1)
  • Bladder dysfunction, autonomic, with impaired pupillary reflex + secondary CAKUT (CHRNA3)
  • Branchio-oto-renal syndrome [panelapp] (SIX1)
  • Branchiooculofacial syndrome (TFAP2A)
  • Branchiootorenal syndrome 1, with/-out cataracts (EYA1)
  • Branchiootorenal syndrome 2 (SIX5)
  • CAKUT + VACTERL association [panelapp] (TRAP1)
  • CAKUT [panelapp] (EXOC3L2)
  • CAKUT [panelapp] (PLVAP)
  • CAKUT [panelapp] (SLIT2)
  • CAKUT [panelapp] (TBC1D1)
  • CAKUT syndrome with/-out hearing loss, abnormal ears/developmental delay (PBX1)
  • CHARGE syndrome (CHD7)
  • COACH syndrome 1 (TMEM67)
  • Cenani-Lenz syndactyly syndrome (LRP4)
  • Congenital anomalies of kidney + urinary tract 1 (DSTYK)
  • Congenital anomalies of kidney + urinary tract 2 (TBX18)
  • Congenital anomalies of kidney + urinary tract 3 (NRIP1)
  • Congenital anomalies of kidney + urinary tract with/-out hearing loss, abn. ears/dev. delay (PBX1)
  • Cornelia de Lange syndrome 1 (NIPBL)
  • Cranioectodermal dysplasia 2 (WDR35)
  • Cranioectodermal dysplasia 4 (WDR19)
  • Duane-radial ray/Okihiro/acrorenoocular syndrome (SALL4)
  • Fanconi anemia, complementation group B (FANCB)
  • Focal segmental glomerulosclerosis 9 (CRB2)
  • Fraser syndrome 1 (FRAS1)
  • Fraser syndrome 2 (FREM2)
  • Fraser syndrome 3 (GRIP1)
  • Glomerulosclerosis, focal segmental, 7 (PAX2)
  • Guttmacher syndrome (HOXA13)
  • Hajdu-Cheney syndrome (NOTCH2)
  • Hand-foot-uterus syndrome (HOXA13)
  • Heterotaxy, visceral, 1, XL (ZIC3)
  • Hypogonadotropic hypogonadism 1 with/-out anosmia, Kallmann syndrome 1 (ANOS1)
  • Hypogonadotropic hypogonadism 5 with/-out anosmia (CHD7)
  • Hypoparathyroidism, sensorineural deafness, and renal dysplasia (GATA3)
  • Joubert syndrome 10 (OFD1)
  • Joubert syndrome 2 (TMEM216)
  • Joubert syndrome 28 (MKS1)
  • Joubert syndrome 29 (TMEM107)
  • Joubert syndrome 34 (B9D2)
  • Joubert syndrome 4 (NPHP1)
  • Joubert syndrome 6 (TMEM67)
  • Joubert syndrome 7 (RPGRIP1L)
  • Kabuki syndrome 1 (KMT2D)
  • Kabuki syndrome 2 (KDM6A)
  • Lymphedema-distichiasis syndrome with renal disease + diabetes mellitus (FOXC2)
  • MIRAGE syndrome (SAMD9)
  • Meckel syndrome 1 (MKS1)
  • Meckel syndrome 10 (B9D2)
  • Meckel syndrome 11 (TMEM231)
  • Meckel syndrome 12 (KIF14)
  • Meckel syndrome 13 (TMEM107)
  • Meckel syndrome 14 (TXNDC15)
  • Meckel syndrome 2 (TMEM216)
  • Meckel syndrome 3 (TMEM67)
  • Meckel syndrome 4 (CEP290)
  • Meckel syndrome 5 (RPGRIP1L)
  • Meckel syndrome 6 (CC2D2A)
  • Meckel syndrome 7 (NPHP3)
  • Meckel syndrome 8 (TCTN2)
  • Meckel syndrome 9 (B9D1)
  • Megabladder, congenital (MYOCD)
  • Megacystis-microcolon-intestinal hypoperistalsis syndrome 1 (MYLK)
  • Megacystis-microcolon-intestinal hypoperistalsis syndrome 2 (MYH11)
  • Megacystis-microcolon-intestinal hypoperistalsis syndrome 3 (LMOD1)
  • Megacystis-microcolon-intestinal hypoperistalsis syndrome 4 (MYL9)
  • Megacystis-microcolon-intestinal hypoperistalsis syndrome 5 (ACTG2)
  • Microcephaly, facial dysmorphism, renal agenesis + ambiguous genitalia syndrome (CTU2)
  • Microphthalmia, syndromic 6 (BMP4)
  • Microphthalmia, syndromic 6 (BNC2)
  • Microphthalmia, syndromic 9 (STRA6)
  • Mitochondrial DNA depletion syndrome 8A, encephalomyopathic type with renal tubulopathy (RRM2B)
  • Mullerian aplasia + hyperandrogenism (WNT4)
  • Multinucleated neurons, anhydramnios, renal dysplasia, cereb. hypoplasia, hydranencephaly (CEP55)
  • Nephronophthisis 1, juvenile (NPHP1)
  • Nephronophthisis 11 (TMEM67)
  • Nephronophthisis 13 (WDR19)
  • Nephronophthisis 2, infantile (INVS)
  • Nephronophthisis 4 (NPHP4)
  • Neurodevelopmental-craniofacial syndrome with variable renal and cardiac abnormalities (ZMYM2)
  • Neurofacioskeletal syndrome with/-out renal agenesis (HS2ST1)
  • Orofaciodigital syndrome I (OFD1)
  • Pallister-Hall syndrome (GLI3)
  • Papillorenal syndrome (PAX2)
  • Polycystic kidney disease 1 (PKD1)
  • Polycystic kidney disease 2 (PKD2)
  • Polycystic kidney disease 3 (GANAB)
  • Polycystic kidney disease 4, with/-out hepatic disease (PKHD1)
  • Prune belly syndrome (CHRM3)
  • RHYNS syndrome (TMEM67)
  • Renal agenesis [panelapp] (RET)
  • Renal cysts + diabetes syndrome (HNF1B)
  • Renal dysplasia [panelapp] (EXOC3L)
  • Renal hypodysplasia/aplasia 1 (ITGA8)
  • Renal hypodysplasia/aplasia 2 (FGF20)
  • Renal hypodysplasia/aplasia 3 (GREB1L)
  • Renal tubular dysgenesis (ACE)
  • Renal tubular dysgenesis (AGTR1)
  • Renal tubular dysgenesis (REN)
  • Renal-hepatic-pancreatic dysplasia 1 (NPHP3)
  • Robinow syndrome, AD 1 (WNT5A)
  • Robinow syndrome, AR (ROR2)
  • SERKAL syndrome (WNT4)
  • Senior-Loken syndrome 1 (NPHP1)
  • Senior-Loken syndrome 3 (SLSN3)
  • Senior-Loken syndrome 4 (NPHP4)
  • Senior-Loken syndrome 5 (IQCB1)
  • Senior-Loken syndrome 6 (CEP290)
  • Senior-Loken syndrome 7 (SDCCAG8)
  • Senior-Loken syndrome 8 (WDR19)
  • Senior-Loken syndrome 9 (TRAF3IP1)
  • Short-rib thoracic dysplasia 5 +/- polydactyly (WDR19)
  • Short-rib thoracic dysplasia 7 +/- polydactyly (WDR35)
  • Simpson-Golabi-Behmel syndrome, type 1 (GPC3)
  • Simpson-Golabi-Behmel syndrome, type 2 (OFD1)
  • Smith-Lemli-Opitz syndrome (DHCR7)
  • Stromme syndrome: intestinal atresia, ocular +/- renal/cardiac abnormalities, microcephaly (CENPF)
  • Structural heart defects + renal anomalies syndrome (TMEM260)
  • Stuve-Wiedemann syndrome/Schwartz-Jampel type 2 syndrome (LIFR)
  • Townes-Brocks branchiootorenal-like syndrome (SALL1)
  • Townes-Brocks syndrome 1 (SALL1)
  • Tubulointerstitial kidney disease, AD, 4 (REN)
  • Urofacial syndrome 1 (HPSE2)
  • Urofacial syndrome 2 (LRIG2)
  • VACTERL association, XL (ZIC3)
  • Ventriculomegaly with cystic kidney disease (CRB2)
  • Vertebral, cardiac, renal + limb defects syndrome 1 (HAAO)
  • Vertebral, cardiac, renal + limb defects syndrome 2 (KYNU)
  • Vertebral, cardiac, renal + limb defects syndrome 3 (NADSYN1)
  • Vertebral, cardiac, tracheoesophageal, renal + limb defects (WBP11)
  • Vesicoureteral reflux 2 (ROBO2)
  • Vesicoureteral reflux 3 (SOX17)
Heredity, heredity patterns etc.
  • AD
  • AR
  • XL
  • XLR
OMIM-Ps
  • Multiple OMIM-Ps
ICD10 Code

Bioinformatics and clinical interpretation

Test-Stärken

  • DAkkS-akkreditiertes Labor
  • EU-Richtlinie für IVD in Umsetzung
  • Qualitäts-kontrolliert arbeitendes Personal
  • Leistungsstarke Sequenzierungstechnologien, fortschrittliche Target-Anreicherungsmethoden und Präzisions-Bioinformatik-Pipelines sorgen für überragende analytische Leistung
  • Sorgfältige Kuratierung klinisch relevanter und wissenschaftlich begründeter Gen-Panels
  • eine Vielzahl nicht Protein-kodierender Varianten, die in unseren klinischen NGS-Tests mit erfasst werden
  • unser strenges Variantenklassifizierungsschema nach ACMG-Kriterien
  • unser systematischer klinischer Interpretations-Workflow mit proprietärer Software ermöglicht die genaue und nachvollziehbare Verarbeitung von NGS-Daten
  • unsere umfassenden klinischen Aussagen

Testeinschränkungen

  • Gene mit eingeschränkter Abdeckung werden gekennzeichnet
  • Gene mit kompletten oder partiellen Duplikationen werden gekennzeichnet
  • es wird angenommen, dass ein Gen suboptimal abgedeckt ist, wenn >90% der Nukleotide des Gens bei einem Mapping-Qualitätsfaktor von >20 (MQ>20) nicht abgedeckt sind
  • die Sensitivität der Diagnostik zur Erkennung von Varianten mit genannten Testeinschränkungen ist möglicherweise begrenzt bei:
  • Gen-Konversionen
  • komplexe Inversionen
  • Balancierte Translokationen
  • Mitochondriale Varianten
  • Repeat-Expansionen, sofern nicht anders dokumentiert
  • nicht kodierende Varianten, die Krankheiten verursachen, die von diesem Panel nicht mit abgedeckt werden
  • niedriger Mosaik-Status
  • Repeat-Blöcke von Mononukleotiden
  • Indels >50bp (Insertionen-Deletionen)
  • Deletionen oder Duplikationen einzelner Exons
  • Varianten innerhalb von Pseudogenen
  • die analytische Sensitivität kann geringer ausfallen werden, wenn die DNA nicht von amedes genetics extrahiert wurde

Laboratory requirement

  • Die in grün gezeigten Gene sind kuratiert und werden als Gen-Panel untersucht. Eine Erweiterung des Panels (blau gezeigte Gene, jeweils ebenfalls kuratiert) kann auf Anfrage erfolgen. Sofern unter "Erweitertes Panel" ein Minuszeichen angezeigt wird, sind nur Core-/Basis-Gene verfügbar.

  • Für die Anforderung einer genetischen Untersuchung senden Sie uns bitte die Krankheits-ID auf einem Überweisungsschein. Bitte die Material-Angabe beachten.

  • Für privat versicherte Patienten empfehlen wir einen Antrag auf Kostenübernahme bei der Krankenversicherung.

  • Die Untersuchung wird auch für Selbstzahler angeboten.